Divi's Labs Q1 results: Profit up 81% at Rs 492 crore
The company logged a profit of Rs 272.44 crore in the year-ago same period, Divi's Laboratories said in a filing to BSE.
By PTI |
Getty Images
New Delhi: Drug firm Divi's Laboratories on Saturday reported 80.61 per cent rise in consolidated net profit at Rs 492.06 crore for June quarter 2020 mainly on account of robust sales.
The company logged a profit of Rs 272.44 crore in the year-ago same period, Divi's Laboratories said in a filing to BSE.
Total income stood at Rs 1,747.80 crore during the quarter under review as against Rs 1,193.20 crore in April-June 2019-20, it added.
"The company has been able to have near normal operations during the quarter and there was minimal impact due to COVID-19 pandemic," Divi's Laboratories said.
The company logged a profit of Rs 272.44 crore in the year-ago same period, Divi's Laboratories said in a filing to BSE.
Total income stood at Rs 1,747.80 crore during the quarter under review as against Rs 1,193.20 crore in April-June 2019-20, it added.
"The company has been able to have near normal operations during the quarter and there was minimal impact due to COVID-19 pandemic," Divi's Laboratories said.
Too busy to trade in stocks? Invest in Mutual Funds with ET Money!
Bookmark or read stories offline -
Download ET Markets APP
Download ET Markets APP
Related Articles
Accenture logs $18 billion Q3 revenue, revenue misses estimatesADVERTISEMENT
